VEGFA and clostridium difficile infection: It is thus surmised that humanized anti-VEGF-A monoclonal antibodies such as Avastin (Bevacizumab) and its biosimilar Mvasi, which have been approved to treat various cancers and eye diseases, could prove useful drugs in managing CDI [106].